Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Biogeneric Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
3SBio
LG life Science
Biosidus
Shanghai Fosun Pharmaceutical
Probiomed
AMEGA Biotech
Teva pharmaceutical industries
Tonghua Dongbao Pharmaceutical
Biocon
Sandoz International
Reliance life sciences
Dong-A Pharmaceutical
By Type:
Insulins
Monoclonal Antibodies
Others
Growth Hormones
By Application:
Research Centers
Hospital
Clinics
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Biogeneric Drugs Market Overview 2018-2029
-
1.1 China Biogeneric Drugs Industry Development Overview
-
1.2 China Biogeneric Drugs Industry Development History
-
1.3 China Biogeneric Drugs Industry Market Size (2018-2029)
-
1.4 China Biogeneric Drugs Market Analysis by Type from Production Side
-
1.4.1 China Biogeneric Drugs Production Volume, Production Value and Growth Rate of Insulins (2018-2029)
-
1.4.2 China Biogeneric Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.4.3 China Biogeneric Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.4 China Biogeneric Drugs Production Volume, Production Value and Growth Rate of Growth Hormones (2018-2029)
-
1.5 China Biogeneric Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Biogeneric Drugs Sales Volume, Sales Value and Growth Rate of Research Centers (2018-2029)
-
1.5.2 China Biogeneric Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.3 China Biogeneric Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.6 China Biogeneric Drugs Market Analysis by Region
-
1.6.1 North China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Biogeneric Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Biogeneric Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Biogeneric Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Biogeneric Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Biogeneric Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Biogeneric Drugs Industry Development
Chapter 3 Biogeneric DrugsIndustry Chain Analysis
-
3.1 Biogeneric Drugs Industry Chain
-
3.2 Biogeneric Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Biogeneric Drugs Market
-
3.3 Biogeneric Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Biogeneric Drugs Market
Chapter 4 China Biogeneric Drugs Market, by Type
-
4.1 China Biogeneric Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Biogeneric Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Biogeneric Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Biogeneric Drugs Production Volume and Growth Rate of Insulins
-
4.5.2 China Biogeneric Drugs Production Volume and Growth Rate of Monoclonal Antibodies
-
4.5.3 China Biogeneric Drugs Production Volume and Growth Rate of Others
-
4.5.4 China Biogeneric Drugs Production Volume and Growth Rate of Growth Hormones
Chapter 5 China Biogeneric Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Biogeneric Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Biogeneric Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Biogeneric Drugs Market Size and Growth Rate of Research Centers
-
5.5.2 China Biogeneric Drugs Market Size and Growth Rate of Hospital
-
5.5.3 China Biogeneric Drugs Market Size and Growth Rate of Clinics
Chapter 6 China Biogeneric Drugs Market, by Region
-
6.1 China Biogeneric Drugs Production Volume and Production Value, by Region
-
6.2 China Biogeneric Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Biogeneric Drugs Market Analysis
-
7.1 North China Biogeneric Drugs Market, by Type
-
7.2 North China Biogeneric Drugs Market, by Application
Chapter 8 Central China Biogeneric Drugs Market Analysis
-
8.1 Central China Biogeneric Drugs Market, by Type
-
8.2 Central China Biogeneric Drugs Market, by Application
Chapter 9 South China Biogeneric Drugs Market Analysis
-
9.1 South China Biogeneric Drugs Market, by Type
-
9.2 South China Biogeneric Drugs Market, by Application
Chapter 10 East China Biogeneric Drugs Market Analysis
-
10.1 East China Biogeneric Drugs Market, by Type
-
10.2 East China Biogeneric Drugs Market, by Application
Chapter 11 Northeast China Biogeneric Drugs Market Analysis
-
11.1 Northeast China Biogeneric Drugs Market, by Type
-
11.2 Northeast China Biogeneric Drugs Market, by Application
Chapter 12 Southwest China Biogeneric Drugs Market Analysis
-
12.1 Southwest China Biogeneric Drugs Market, by Type
-
12.2 Southwest China Biogeneric Drugs Market, by Application
Chapter 13 Northwest China Biogeneric Drugs Market Analysis
-
13.1 Northwest China Biogeneric Drugs Market, by Type
-
13.2 Northwest China Biogeneric Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 3SBio
-
14.1.1 3SBio Company Profile
-
14.1.2 3SBio Biogeneric Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 LG life Science
-
14.2.1 LG life Science Company Profile
-
14.2.2 LG life Science Biogeneric Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Biosidus
-
14.3.1 Biosidus Company Profile
-
14.3.2 Biosidus Biogeneric Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Shanghai Fosun Pharmaceutical
-
14.4.1 Shanghai Fosun Pharmaceutical Company Profile
-
14.4.2 Shanghai Fosun Pharmaceutical Biogeneric Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Probiomed
-
14.5.1 Probiomed Company Profile
-
14.5.2 Probiomed Biogeneric Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 AMEGA Biotech
-
14.6.1 AMEGA Biotech Company Profile
-
14.6.2 AMEGA Biotech Biogeneric Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Teva pharmaceutical industries
-
14.7.1 Teva pharmaceutical industries Company Profile
-
14.7.2 Teva pharmaceutical industries Biogeneric Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Tonghua Dongbao Pharmaceutical
-
14.8.1 Tonghua Dongbao Pharmaceutical Company Profile
-
14.8.2 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Biocon
-
14.9.1 Biocon Company Profile
-
14.9.2 Biocon Biogeneric Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Sandoz International
-
14.10.1 Sandoz International Company Profile
-
14.10.2 Sandoz International Biogeneric Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Reliance life sciences
-
14.11.1 Reliance life sciences Company Profile
-
14.11.2 Reliance life sciences Biogeneric Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Dong-A Pharmaceutical
-
14.12.1 Dong-A Pharmaceutical Company Profile
-
14.12.2 Dong-A Pharmaceutical Biogeneric Drugs Market Performance
-
14.12.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Biogeneric Drugs Industry Research Conclusions
-
15.2 Biogeneric Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Biogeneric Drugs Industry Market Size (2018-2029)
-
Figure China Biogeneric Drugs Production Volume, Production Value and Growth Rate of Insulins (2018-2029)
-
Figure China Biogeneric Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure China Biogeneric Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Biogeneric Drugs Production Volume, Production Value and Growth Rate of Growth Hormones (2018-2029)
-
Figure China Biogeneric Drugs Sales Volume, Sales Value and Growth Rate of Research Centers (2018-2029)
-
Figure China Biogeneric Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Biogeneric Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure North China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Biogeneric Drugs Market Size and Growth Rate from 2018-2029
-
Figure Biogeneric Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Biogeneric Drugs Market Share by Type in 2018
-
Figure China Biogeneric Drugs Market Share by Type in 2023
-
Figure China Biogeneric Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Biogeneric Drugs Production Volume and Growth Rate of Insulins (2018-2023)
-
Figure China Biogeneric Drugs Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Figure China Biogeneric Drugs Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Biogeneric Drugs Production Volume and Growth Rate of Growth Hormones (2018-2023)
-
Figure China Biogeneric Drugs Market Share by Application in 2018
-
Figure China Biogeneric Drugs Market Share by Application in 2023
-
Figure China Biogeneric Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Biogeneric Drugs Market Size and Growth Rate of Research Centers (2018-2023)
-
Figure China Biogeneric Drugs Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Biogeneric Drugs Market Size and Growth Rate of Clinics (2018-2023)
-
Table China Biogeneric Drugs Production Volume by Region (2018-2023)
-
Table China Biogeneric Drugs Production Volume Share by Region (2018-2023)
-
Figure China Biogeneric Drugs Production Volume Share by Region (2018-2023)
-
Table China Biogeneric Drugs Production Value by Region (2018-2023)
-
Table China Biogeneric Drugs Production Value Share by Region (2018-2023)
-
Figure China Biogeneric Drugs Production Value Share by Region (2018-2023)
-
Table China Biogeneric Drugs Sales Volume by Region (2018-2023)
-
Table China Biogeneric Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Biogeneric Drugs Sales Volume Share by Region (2018-2023)
-
Table China Biogeneric Drugs Sales Value by Region (2018-2023)
-
Table China Biogeneric Drugs Sales Value Share by Region (2018-2023)
-
Figure China Biogeneric Drugs Sales Value Share by Region (2018-2023)
-
Table North China Biogeneric Drugs Production Volume by Type (2018-2023)
-
Table North China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Table North China Biogeneric Drugs Sales Volume by Application (2018-2023)
-
Table North China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Biogeneric Drugs Production Volume by Type (2018-2023)
-
Table Central China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Biogeneric Drugs Sales Volume by Application (2018-2023)
-
Table Central China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Biogeneric Drugs Production Volume by Type (2018-2023)
-
Table South China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Table South China Biogeneric Drugs Sales Volume by Application (2018-2023)
-
Table South China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Biogeneric Drugs Production Volume by Type (2018-2023)
-
Table East China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Table East China Biogeneric Drugs Sales Volume by Application (2018-2023)
-
Table East China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Biogeneric Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Biogeneric Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Biogeneric Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Biogeneric Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Biogeneric Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Biogeneric Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Biogeneric Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Biogeneric Drugs Sales Volume Share by Application (2018-2023)
-
Table 3SBio Company Profile
-
Table 3SBio Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table LG life Science Company Profile
-
Table LG life Science Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Biosidus Company Profile
-
Table Biosidus Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Shanghai Fosun Pharmaceutical Company Profile
-
Table Shanghai Fosun Pharmaceutical Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Probiomed Company Profile
-
Table Probiomed Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table AMEGA Biotech Company Profile
-
Table AMEGA Biotech Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Teva pharmaceutical industries Company Profile
-
Table Teva pharmaceutical industries Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Tonghua Dongbao Pharmaceutical Company Profile
-
Table Tonghua Dongbao Pharmaceutical Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Biocon Company Profile
-
Table Biocon Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Sandoz International Company Profile
-
Table Sandoz International Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Reliance life sciences Company Profile
-
Table Reliance life sciences Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
Table Dong-A Pharmaceutical Company Profile
-
Table Dong-A Pharmaceutical Biogeneric Drugs Revenue, Price and Gross (2018-2023)
-
